Bendroflumethiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for bendroflumethiazide and what is the scope of freedom to operate?
Bendroflumethiazide
is the generic ingredient in five branded drugs marketed by Apothecon, King Pharms Llc, Impax Labs, and Mylan, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for bendroflumethiazide.
Summary for bendroflumethiazide
US Patents: | 0 |
Tradenames: | 5 |
Applicants: | 4 |
NDAs: | 4 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 4 |
Patent Applications: | 6,270 |
Formulation / Manufacturing: | see details |
DailyMed Link: | bendroflumethiazide at DailyMed |
Recent Clinical Trials for bendroflumethiazide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1 |
Mylan Pharmaceuticals | Phase 1 |
Steno Diabetes Center | Phase 4 |
Medical Subject Heading (MeSH) Categories for bendroflumethiazide
US Patents and Regulatory Information for bendroflumethiazide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-002 | May 25, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
King Pharms Llc | CORZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 018647-001 | May 25, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Impax Labs | NADOLOL AND BENDROFLUMETHIAZIDE | bendroflumethiazide; nadolol | TABLET;ORAL | 077833-001 | Mar 30, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |